Filing Details

Accession Number:
0001209191-16-092883
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-01-21 16:13:01
Reporting Period:
2016-01-20
Filing Date:
2016-01-21
Accepted Time:
2016-01-21 16:13:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1385818 Aytu Bioscience Inc AYTU Pharmaceutical Preparations (2834) 470883144
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1566240 R. Joshua Disbrow 373 Inverness Parkway
Suite 206
Englewood CO 80112
Chief Executive Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-01-20 153,846 $0.65 153,846 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Employee Stock Option Grant $1.51 2025-11-11 600,000 600,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2025-11-11 600,000 600,000 Direct
Footnotes
  1. These shares were purchased by the Reporting Person pursuant to a subscription agreement with the Issuer, dated January 20, 2016, which closed on January 20, 2016, and are restricted for resale indefinitely.
  2. 33.33% vests on the one year, two year and three year anniversary of the date of grant, subject to the Grantee's continued service as an employee on such dates.